Mair, M. J., Hartenbach, S., Tomasich, E., Maas, S. L. N., Bosch, S. A., Widhalm, G., . . . Albert, N. L. (2025). Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma. European Journal of Nuclear Medicine & Molecular Imaging, 52(8), 2771. https://doi.org/10.1007/s00259-025-07075-8
Chicago Style (17th ed.) CitationMair, Maximilian J., et al. "Expression of SSTR2a, FAP, HER2 and HER3 as Potential Radionuclide Therapy Targets in Higher-grade Meningioma." European Journal of Nuclear Medicine & Molecular Imaging 52, no. 8 (2025): 2771. https://doi.org/10.1007/s00259-025-07075-8.
MLA (9th ed.) CitationMair, Maximilian J., et al. "Expression of SSTR2a, FAP, HER2 and HER3 as Potential Radionuclide Therapy Targets in Higher-grade Meningioma." European Journal of Nuclear Medicine & Molecular Imaging, vol. 52, no. 8, 2025, p. 2771, https://doi.org/10.1007/s00259-025-07075-8.